Unveiling Medication-Related Osteonecrosis of the Jaw: A Rapid Review of Etiology, Drug Holidays, and Treatment Strategies

• Published in: Applied sciences Vol. 14; no. 8; p. 3314
• Main Authors: Oh, Ji-Hyeon, Kim, Seong-Gon
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01-04-2024
• Subjects: Bones; Denosumab; Dental implants; drug holiday; Drug therapy; Epidemiology; Evidence-based medicine; Homeopathy; incidence; Jaw; Males; Materia medica and therapeutics; medication-related osteonecrosis of the jaw; Necrosis; Osteoporosis; Patients; Systematic review; Tetracycline; Tetracyclines; Therapeutics; tooth extraction; treatment
• ISSN: 2076-3417; 2076-3417
• DOI: 10.3390/app14083314

This rapid review critically evaluates recent advancements in the management of medication-related osteonecrosis of the jaw (MRONJ) from 2022 to 2023, employing a specific article selection protocol to focus on the latest literature. Initially screening 262 articles and ultimately selecting 22 based on their relevance and uniqueness, the process involved meticulous screening, methodological evaluation, and data extraction by the authors. The findings, organized into epidemiology, treatment effectiveness, and drug holidays, are synthesized following rapid review guidelines. The review addresses the risk of MRONJ associated with tooth extraction in patients undergoing antiresorptive medication therapy, such as bisphosphonates (BPs) and denosumab (DS), and evaluates the effectiveness of drug holidays in reducing this risk. Recent studies suggest that drug holidays may not effectively mitigate MRONJ risks as previously believed. Furthermore, it highlights that conservative treatment can benefit asymptomatic early-stage MRONJ patients, whereas surgical intervention is more effective for those in advanced stages. Ultimately, this review synthesizes current findings to enhance clinical practice, suggesting that while drug holidays may not significantly reduce MRONJ risks, treatment strategies should be tailored, ranging from conservative approaches in early stages to surgical interventions in advanced stages, thereby guiding evidence-based clinical decisions.